Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-country, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of STA363 at Two Concentrations (60 mg/mL and 120 mg/mL) Compared to Placebo in Patients With Chronic Discogenic Low Back Pain

Next Previous
Search
Trial Profile

A Multi-country, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of STA363 at Two Concentrations (60 mg/mL and 120 mg/mL) Compared to Placebo in Patients With Chronic Discogenic Low Back Pain

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Apr 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lactic acid (Primary)
  • Indications Back pain; Intervertebral disc degeneration
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 03 Apr 2024 According to a Stayble Therapeutics media release, the abstract has been accepted for a poster presentation at the International Society for the Study of the Lumbar Spine (ISSLS) annual meeting in Milan, Italy, on 27-31 May 2024.
    • 06 Sep 2023 According to a Stayble Therapeutics media release, a total of 110 patients were included, of which 106 completed their six-month visit, which is the primary endpoint of the study, and a total of 101 completed their twelve-month visit.
    • 06 Sep 2023 According to a Stayble Therapeutics media release, the company has completed four follow-up visits (after one, three, six and twelve months).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top